Improves absorption and bioavailability
In particular, cancer cells appear to exhibit significant levels of HDM2 in their membranes, whereas non-transformed or non-cancerous cells do not appear to have substantial levels of HDM2
Studies have demonstrated that a patient with advanced ALS experienced a slowed progression of the disease after receiving melatonin, while two other patients exhibited decreased rates of decline at a subsequent evaluation, as reported by Jacob et al
10.1089/acm.2006.12.881 [DOI] [PubMed] [Google Scholar] Associated Data This section collects any data citations, data availability statements, or supplementary materials included in this article
--- Potential Risks and Considerations Because BPC-157 and TB-500 are not approved veterinary drugs, potential risks may include: Unknown long-term safety effects Variability in product quality or sterility Contamination risks with unregulated suppliers Potential interactions with other medications or supplements Owner supervision alone is not a substitute for veterinary guidance